MK-3475 for Metastatic Inflammatory Breast Cancer (MIBC)

Condition:   Breast CancerInterventions:   Drug: MK-3475;   Behavioral: Follow Up/Phone CallSponsors:   M.D. Anderson Cancer Center;   Merck Sharp & Dohme Corp.Not yet recruiting - verified May 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials